NUVL Nuvalent Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: NUVL

Price (delayed)

$94.58

Market cap

$7.47B

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$6.06

Enterprise value

$7.31B

?
Relative Growth: Rel. Growth: 2
Relative Strength: Rel. Strength: 42
Relative Valuation: Rel. Valuation: N/A
Relative Profitability: Rel. Profitability: 4
Highlights
NUVL's quick ratio is up by 11% year-on-year and by 6% since the previous quarter
The equity has increased by 16% year-on-year but it has declined by 6% since the previous quarter
Nuvalent's net income has decreased by 50% YoY and by 6% QoQ
The EPS has contracted by 38% YoY and by 3.6% from the previous quarter
Sector: Healthcare
Industry: Biotechnology
Peers: EA TTWO

Key stats

What are the main financial stats of NUVL

NUVL stock price

How has the Nuvalent stock price performed over time
Intraday
4.88%
1 week
-13.44%
1 month
-7.83%
1 year
23.12%
YTD
-5.97%
QTD
-7.68%

Financial performance

How have Nuvalent's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$438.9M
Net income
-$450.07M
Gross margin
N/A
Net margin
N/A
Nuvalent's net income has decreased by 50% YoY and by 6% QoQ
The operating income has declined by 36% year-on-year and by 6% since the previous quarter

Price vs fundamentals

How does NUVL's price correlate with its fundamentals

Growth

What is Nuvalent's growth rate over time

Valuation

What is Nuvalent stock price valuation
P/E
N/A
P/B
6.33
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
The EPS has contracted by 38% YoY and by 3.6% from the previous quarter
NUVL's P/B is 16% higher than its 5-year quarterly average of 5.2 but 7% lower than its last 4 quarters average of 6.5
The equity has increased by 16% year-on-year but it has declined by 6% since the previous quarter

Efficiency

How efficient is Nuvalent business performance
Nuvalent's return on equity has decreased by 37% YoY
The ROA has decreased by 29% YoY
The ROIC has declined by 26% year-on-year

Dividends

What is NUVL's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for NUVL.

Financial health

How did Nuvalent financials performed over time
The total liabilities has surged by 65% year-on-year but it has declined by 4.6% since the previous quarter
The total assets is up by 20% year-on-year but it is down by 6% since the previous quarter
The debt is 100% smaller than the equity
The equity has increased by 16% year-on-year but it has declined by 6% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.